A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.

@article{Olsson2009ARD,
  title={A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.},
  author={Erik Martin Gustaf Olsson and Bo von Sch{\'e}ele and Alexander G. Panossian},
  journal={Planta medica},
  year={2009},
  volume={75 2},
  pages={
          105-12
        }
}
The aim of the study was to assess the efficacy of the standardised extract SHR-5 of roots of Rhodiola Rosea L. in the treatment of individuals suffering from stress-related fatigue. The phase III clinical trial took the form of a randomised, double-blind, placebo-controlled study with parallel groups. Participants, males and females aged between 20 and 55 years, were selected according to the Swedish National Board of Health and Welfare diagnostic criteria for fatigue syndrome. A total of 60… 

Figures and Tables from this paper

Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial
TLDR
2 × 200 mg WS® 1375 may be an effective treatment in subjects suffering from prolonged or chronic fatigue in an uncontrolled, open-label multicenter clinical trial.
Therapeutic Effects and Safety of Rhodiola rosea Extract WS® 1375 in Subjects with Life‐stress Symptoms – Results of an Open‐label Study
TLDR
Rhodiola extract at a dose of 200 mg twice daily for 4 weeks is safe and effective in improving life‐stress symptoms to a clinically relevant degree.
Burnout: Evaluation of the efficacy and tolerability of TARGET 1® for professional fatigue syndrome (burnout)*
TLDR
TARGET 1® significantly improved the symptoms of burnout after 12 weeks’ use and the verum group consistently showed significantly greater improvements in scores than the placebo group.
The Effects of an Acute Dose of Rhodiola rosea on Endurance Exercise Performance
TLDR
Acute R. rosea ingestion decreases heart rate response to submaximal exercise and appears to improve endurance exercise performance by decreasing the perception of effort.
Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease – A Randomized Placebo Controlled Double Blind Clinical Trial
TLDR
Rhodiola crenulata (RC) did not improve the six-minute walk test distance but significantly improved tidal breathing and ventilation efficiency, most likely through improvements in work rate, and tended to protect against acute exacerbation of COPD.
Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms
TLDR
A wide range of outcome measures associated with the syndrome clearly improved during administration of the study drug over the course of 12 weeks, and provide an encouraging basis for clinical trials further investigating the clinical outcomes of R. rosea extract in patients with the burnout syndrome.
Rhodiola Rosea for Mental and Physical Fatigue in Nursing Students: A Randomized Controlled Trial
TLDR
This study indicates that among nursing students on shift work, a 42-day course of R. Rosea compared with placebo worsened fatigue; however, the results should be interpreted with caution.
Scientific opinion on the substantiation of a health claim related to Rhodiola rosea L. extract and reduction of mental fatigue pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
TLDR
The Panel concludes that a cause and effect relationship has not been established between the consumption of Rhodiola rosea L.extract and reduction of mental fatigue.
Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
TLDR
The aim of this review article is to assess the level of scientific evidence presented by clinical trials of adaptogens in fatigue, and to provide a rationale at the molecular level for verified effects of Rhodiola rosea SHR-5 extract.
...
...

References

SHOWING 1-10 OF 42 REFERENCES
Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
TLDR
It is concluded that the standardized extract SHR-5 shows anti-depressive potency in patients with mild to moderate depression when administered in dosages of either 340 or 680 mg/day over a 6-week period.
Comparative study of Rhodiola preparations on behavioral despair of rats.
Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice
TLDR
Evidence of the efficacy of R. rosea extracts after a single administration is provided, and many preclinical and clinical studies indicating the adaptogenic and stimulating effects of such R.rosea extracts are confirmed, as antidepressant‐like and anxiolytic‐like activities of R.'s rosea were shown for the first time.
Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats
TLDR
It is strongly demonstrated that RHO is able selectively to attenuate stress-induced anorexia, providing functional evidence of claimed adaptogen and anti-stress properties of Rhodiola rosea L.
Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory.
TLDR
It has been found that Rhodiola extract in a single dose of 0.10 ml per rat essentially improves learning and retention after 24 hours and significant improvement of the long-term memory is also established in memory tests after 10-day treatment with the same dose of the extract.
A New Depression Scale Designed to be Sensitive to Change
TLDR
The construction of a depression rating scale designed to be particularly sensitive to treatment effects is described, and its capacity to differentiate between responders and non-responders to antidepressant treatment was better than the HRS, indicating greater sensitivity to change.
...
...